Riboflavin
Unchecked
From Pharmacopedia
More actions
Experience
No personal reports yet
No clinical reports yet
Log in to add your own experience.
Problems
No problems yet. Be the first to suggest one.
+ Add a problemTitration strategies
No titration strategies yet. Be the first to suggest one.
Effects
No effects listed yet. Be the first to suggest one.
Relevant anecdote
No anecdotes yet. Share a relevant one.
Relevant Literature
No literature entries yet.
Log in to submit relevant literature.
Summary
Common uses
Riboflavin deficiency (ariboflavinosis)0, Migraine prophylaxis (high-dose, evidence-based)0, Selected inborn errors of metabolism (riboflavin-responsive multiple acyl-CoA dehydrogenase deficiency, others)0
Pharmacy
Starting dose
Migraine prophylaxis: 400 mg PO daily; deficiency replacement 5-30 mg/d
Preparations
25, 50, 100, 250, 400 mg tablets; OTC
US FDA Max
No strict ceiling for water-soluble vitamin; UL not set
Pharmacology
Routes
Oral, IV (rare)
Onset
Migraine effect after 1-3 months of daily use
Duration
N/A
Half-life
~1-2 hours plasma (riboflavin itself); FAD/FMN tissue cofactors are continuous
Bioavailability
~50-60% (oral; food enhances)
Pregnancy
Safe at replacement and supplement doses.[citation needed]
Legal status
OTC in US
Purported mechanism
Riboflavin is the dietary precursor of the flavin cofactors FAD and FMN, which are essential electron carriers for mitochondrial oxidative phosphorylation (complex I and II), fatty acid β-oxidation, and many oxidoreductase reactions; the migraine prophylactic effect is hypothesized to act via improvement of mitochondrial energetics in migraine-susceptible neurons.0 The 400 mg/d dose for migraine prophylaxis is supported by randomized trials (Schoenen 1998) and remains a low-risk evidence-based supplement option. Characteristic bright-yellow urine fluorescence with high-dose oral supplementation.